What is Mizuho's price target for ACAD?

Mizuho's latest stated price target for ACADIA Pharmaceuticals Inc. (ACAD) is $35, from its action on Feb 23, 2026.

What is Mizuho's rating on ACAD?

Mizuho rates ACAD Outperform, a bullish rating, as of Feb 23, 2026.

When did Mizuho last change its view on ACAD?

On Feb 23, 2026, Mizuho upgrades to Outperform from Neutral, price target $35.

Mizuho ACAD price target and rating history

ACADIA Pharmaceuticals Inc. (ACAD) · Health Care

Mizuho rates ACADIA Pharmaceuticals Inc. (ACAD) Outperform with a $35 price target, as of its latest action on Feb 23, 2026. It has published 5 rating actions on ACAD since December 2021, including 2 upgrades and 1 downgrade. Across 4 firms with a ACAD price target in the last 12 months, the median target is $31. Mizuho's $35 is 13% above that.

Current rating: Outperform
Price target: $35
Median target, all firms: $31
Actions on ACAD: 5

Mizuho price target on ACAD

Mizuho price target on ACAD, each point a stated target, December 2021 to February 2026.

Every Mizuho rating on ACAD

Feb 23, 2026
UpgradeMizuho upgrades to Outperform from Neutral, price target $35
Mar 12, 2024
DowngradeMizuho downgrades to Neutral from Buy, price target $39 to $25
Nov 6, 2023
UpgradeMizuho upgrades to Buy from Neutral, price target $20 to $35
Mar 3, 2022
ReiterateMizuho cuts its price target to $28 from $33, keeps Neutral
Dec 7, 2021
ReiterateMizuho raises its price target to $26 from $24, keeps Neutral

How other firms rate ACAD

Each firm's latest rating and stated target in the last 12 months.

Firm	Rating	Price target	Date
UBS	Neutral	$23	Oct 13, 2026
BofA Securities	Buy	$29	Mar 25, 2026
Wolfe Research	Outperform	$33	Feb 24, 2026
Mizuho	Outperform	$35	Feb 23, 2026

Questions about Mizuho and ACAD

What is Mizuho's price target for ACAD?: Mizuho's latest stated price target for ACADIA Pharmaceuticals Inc. (ACAD) is $35, from its action on Feb 23, 2026.
What is Mizuho's rating on ACAD?: Mizuho rates ACAD Outperform, a bullish rating, as of Feb 23, 2026.
When did Mizuho last change its view on ACAD?: On Feb 23, 2026, Mizuho upgrades to Outperform from Neutral, price target $35.
How does Mizuho's ACAD target compare with other analysts?: Across 4 firms with a ACAD price target in the last 12 months, the median target is $31. Mizuho's $35 is 13% above that.

More ACAD rating histories

All Mizuho ratings ACAD news and filings Every analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.